- $31.18m
- $31.46m
- $27.04m
- 40
- 63
- 38
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.43 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.15 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -60.68% | ||
| Return on Equity | -62.97% | ||
| Operating Margin | -229.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 7.58 | 20.51 | 27.66 | 20.35 | 27.04 | 32.45 | 38.93 | 29.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Directors
- Yoav Shaked NEC (49)
- Richard Anderson PRE (51)
- Erez Raphael CEO (47)
- Zvi Ben-David CFO (60)
- Dror Bacher COO (46)
- Chris Chan SVP
- Oded Cohen SVP (50)
- Claudia Kraut VPR
- Jerrod Helms OTH
- Adam Stern DRC (57)
- Hila Karah IND (52)
- Dennis Matheis IND (60)
- Dennis Mcgrath IND (64)
- Richard Stone IND (78)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 11th, 2011
- Public Since
- March 8th, 2013
- No. of Shareholders
- 328
- No. of Employees
- 196
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 41,567,016
- Address
- 322 W 57Th St. #33B, NEW YORK, 10019
- Web
- https://shop.mydario.com/
- Phone
- +1 6466654667
- Auditors
- Kost, Forer, Gabbay & Kasierer
Upcoming Events for DRIO
Q2 2025 DarioHealth Corp Earnings Release
Similar to DRIO
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the DarioHealth share price?
As of Today at 20:11 UTC, shares in DarioHealth are trading at $0.75. This share price information is delayed by 15 minutes.
How has the DarioHealth share price performed this year?
Shares in DarioHealth last closed at $0.75 and the price had moved by -50.66% over the past 365 days. In terms of relative price strength the DarioHealth share price has underperformed the S&P500 Index by -55.51% over the past year.
What are the analyst and broker recommendations for DarioHealth?
The overall consensus recommendation for DarioHealth is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the DarioHealth dividend yield?
DarioHealth does not currently pay a dividend.
Does DarioHealth pay a dividend?
DarioHealth does not currently pay a dividend.
When does DarioHealth next pay dividends?
DarioHealth does not currently pay a dividend.
How do I buy DarioHealth shares?
To buy shares in DarioHealth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DarioHealth?
As of the previous close price of $0.75, shares in DarioHealth had a market capitalisation of $31.18m.
Where are DarioHealth shares listed?
Here are the trading details for DarioHealth:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: DRIO
What kind of share is DarioHealth?
Based on an overall assessment of its quality, value and momentum DarioHealth is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DarioHealth share price forecast for 2025?
The analyst consensus target price for shares in DarioHealth is $2.67. That is 256% above the last closing price of $0.75.
Analysts covering DarioHealth currently have a consensus Earnings Per Share (EPS) forecast of -$0.33 for the next financial year.
Find out moreWhat is the trend in the DarioHealth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DarioHealth. Over the past six months, its share price has underperformed the S&P500 Index by -20.48%.
As of the last closing price of $0.75, shares in DarioHealth were trading -8.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DarioHealth PE Ratio?
The DarioHealth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DarioHealth?
DarioHealth's management team is headed by:
- Yoav Shaked - NEC
- Richard Anderson - PRE
- Erez Raphael - CEO
- Zvi Ben-David - CFO
- Dror Bacher - COO
- Chris Chan - SVP
- Oded Cohen - SVP
- Claudia Kraut - VPR
- Jerrod Helms - OTH
- Adam Stern - DRC
- Hila Karah - IND
- Dennis Matheis - IND
- Dennis Mcgrath - IND
- Richard Stone - IND